Red Cell Distribution Width to Lymphocyte Ratio Could Serve As a New Inflammatory Biomarker for Predicting Hematoma Expansion in Patients with Intracerebral Hemorrhage

Overview

Journal BMC Neurol

Publisher Biomed Central

Specialty Neurology

Date 2024 May 15

PMID 38750430

Authors

Milad Babaei Guilan

Seyed Reza Bagheri

Rezvan Roshani

Ehsan Alimohammadi

Affiliations

Soon will be listed here.

Abstract

Background: Hematoma expansion is a critical factor associated with increased mortality and adverse outcomes in patients with intracerebral hemorrhage (ICH). Identifying and preventing hematoma expansion early on is crucial for effective therapeutic intervention. This study aimed to investigate the potential association between the Red cell distribution width to lymphocyte ratio (RDWLR) and hematoma expansion in ICH patients.

Methods: We conducted a retrospective analysis of clinical data from 303 ICH patients treated at our department between May 2018 and May 2023. Demographic, clinical, radiological, and laboratory data, including RDWLR upon admission, were assessed. Binary logistic regression analysis was employed to determine independent associations between various variables and hematoma expansion.

Results: The study included 303 ICH patients, comprising 167 (55.1%) males and 136 (44.9%) females, with a mean age of 65.25 ± 7.32 years at admission. Hematoma expansion occurred in 73 (24.1%) cases. Multivariate analysis revealed correlations between hematoma volume at baseline (OR, 2.73; 95% CI: 1.45 -4,78; P < 0.001), admission systolic blood pressure (OR, 2.98 ; 95% CI: 1.54-4.98; P < 0.001), Glasgow Coma Scale (GCS) (OR, 1.58; 95% CI: 1.25-2.46; P = 0.017), and RDWLR (OR, 1.58; 95% CI: 1.13-2.85; P = 0.022) and hematoma expansion in these patients.

Conclusions: Our findings suggest that RDWLR could serve as a new inflammatory biomarker for hematoma expansion in ICH patients. This cost-effective and readily available biomarker has the potential for early prediction of hematoma expansion in these patients.

References

Patel K, Ferrucci L, Ershler W, Longo D, Guralnik J . Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009; 169(5):515-23. PMC: 2765040. DOI: 10.1001/archinternmed.2009.11. View

Brouwers H, Chang Y, Falcone G, Cai X, Ayres A, Battey T . Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol. 2013; 71(2):158-64. PMC: 4131760. DOI: 10.1001/jamaneurol.2013.5433. View

Corps K, Roth T, McGavern D . Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015; 72(3):355-62. PMC: 5001842. DOI: 10.1001/jamaneurol.2014.3558. View

Schwartz M, Moalem G . Beneficial immune activity after CNS injury: prospects for vaccination. J Neuroimmunol. 2001; 113(2):185-92. DOI: 10.1016/s0165-5728(00)00447-1. View

Garcez M, Peres W, Salvador M . Oxidative stress and hematologic and biochemical parameters in individuals with Down syndrome. Mayo Clin Proc. 2005; 80(12):1607-11. DOI: 10.4065/80.12.1607. View

Zhang Z, Li J, Ye Q, Dong Y, Bao G, Shen Y . Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury. Clin Chim Acta. 2019; 497:6-12. DOI: 10.1016/j.cca.2019.07.008. View

Mazzeo A, Kunene N, Gilman C, Hamm R, Hafez N, Ross Bullock M . Severe human traumatic brain injury, but not cyclosporin a treatment, depresses activated T lymphocytes early after injury. J Neurotrauma. 2006; 23(6):962-75. DOI: 10.1089/neu.2006.23.962. View

Melmed K, Lyden P, Gellada N, Moheet A . Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin. J Stroke Cerebrovasc Dis. 2017; 26(8):1874-1882. DOI: 10.1016/j.jstrokecerebrovasdis.2017.04.025. View

Pinho J, Silva L, Quintas-Neves M, Marques L, Amorim J, Reich A . Red Cell Distribution Width is Associated with 30-day Mortality in Patients with Spontaneous Intracerebral Hemorrhage. Neurocrit Care. 2020; 34(3):825-832. PMC: 8179905. DOI: 10.1007/s12028-020-01103-1. View

10.

Jassam Y, Izzy S, Whalen M, McGavern D, El Khoury J . Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift. Neuron. 2017; 95(6):1246-1265. PMC: 5678753. DOI: 10.1016/j.neuron.2017.07.010. View

11.

He J, Zhang Y, Hao P, Li T, Xiao Y, Peng L . Association Between Red Blood Cell Distribution width and Long-Term Mortality in Patients with Intracerebral Hemorrhage. Neurocrit Care. 2023; 40(3):1059-1069. DOI: 10.1007/s12028-023-01875-2. View

12.

Dowlatshahi D, Demchuk A, Flaherty M, Ali M, Lyden P, Smith E . Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011; 76(14):1238-44. PMC: 3068004. DOI: 10.1212/WNL.0b013e3182143317. View

13.

Alimohammadi E, Bagheri S, Mardanpour P, Moradi F, Arjmandnia F, Esmaeili N . Baseline neutrophil-lymphocyte ratio can be associated with hematoma expansion in patients with intracerebral hemorrhage: a retrospective observational study. BMC Neurosci. 2022; 23(1):18. PMC: 8957183. DOI: 10.1186/s12868-022-00705-z. View

14.

Meisel C, Schwab J, Prass K, Meisel A, Dirnagl U . Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005; 6(10):775-86. DOI: 10.1038/nrn1765. View

15.

Felker G, Allen L, Pocock S, Shaw L, McMurray J, Pfeffer M . Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007; 50(1):40-7. DOI: 10.1016/j.jacc.2007.02.067. View

16.

Wada R, Aviv R, Fox A, Sahlas D, Gladstone D, Tomlinson G . CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007; 38(4):1257-62. DOI: 10.1161/01.STR.0000259633.59404.f3. View

17.

Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M . Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage. Stroke. 2016; 47(6):1654-7. DOI: 10.1161/STROKEAHA.116.013627. View

18.

Roh D, Sun C, Murthy S, Elkind M, Bruce S, Melmed K . Hematoma Expansion Differences in Lobar and Deep Primary Intracerebral Hemorrhage. Neurocrit Care. 2019; 31(1):40-45. PMC: 6609462. DOI: 10.1007/s12028-018-00668-2. View

19.

Schwulst S, Trahanas D, Saber R, Perlman H . Traumatic brain injury-induced alterations in peripheral immunity. J Trauma Acute Care Surg. 2013; 75(5):780-8. PMC: 3809060. DOI: 10.1097/TA.0b013e318299616a. View

20.

Smrcka M, Mrlian A, Klabusay M . Immune system status in the patients after severe brain injury. Bratisl Lek Listy. 2005; 106(3):144-6. View